openPR Logo
Press release

52Platform Introduces Bleuler: A Revolutionary Advance in Schizophrenia Treatment Personalization

01-24-2025 09:14 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Getnews

/ PR Agency: Notorial
52Platform Introduces Bleuler: A Revolutionary Advance

Image: https://www.globalnewslines.com/uploads/2025/01/1737641669.jpg

Barcelona - January 24, 2025 - 52Platform [https://www.52platform.com/], a leader in neuroscientific innovation, has announced Bleuler, a groundbreaking project to develop a platform designed to transform the treatment of schizophrenia. Engineered with the most advanced capabilities of artificial intelligence, Bleuler aims to provide personalized solutions based on precise data. This international project involves collaboration with Synaptia Health Group [https://synaptia.es/] in Spain, MJN Neuro, the National Institute of Neurology and Neurosurgery "Manuel Velasco Suarez" in Mexico, and Rey Juan Carlos University.

Schizophrenia affects over 25 million people worldwide. This disorder presents significant challenges due to variability in patient responses to current treatments. Bleuler, still in the study phase, focuses on developing an innovative clinical approach that combines electroencephalographic biomarkers and advanced cognitive assessments through artificial intelligence.

"Bleuler has the potential to revolutionize the medical care of schizophrenia", stated Adrian Trejo de la Rosa [https://www.linkedin.com/in/adrian-trejo-de-la-rosa/?originalSubdomain=es], CEO and co-founder of 52Platform. "This project is a step towards more precise treatment that will improve the quality of life for patients and provide doctors with reliable technological tools for making critical decisions. Our vision does not stop here; we want to expand this model to other neurological disorders and continue leading the future of personalized medicine".

The development of Bleuler will be possible thanks to a grant of 973,811.33 Euros from a total budget of 1,604,067 Euros, awarded by the Center for Technological Development and Innovation (CDTI), a Public Business Entity under the Ministry of Science, Innovation, and Universities. This funding, as part of its program to support high-impact R&D projects, will allow progress in research, validate the technology, and refine the platform's design.

Technological Innovation at the Service of Patients

Bleuler seeks to detect early clinical changes in patients and adjust treatments according to their individual needs. Current studies include the development of wearable devices capable of monitoring brain activity from home, combined with automated cognitive analysis systems. These tools are designed to improve the quality of care and reduce unnecessary hospitalizations.

The project is expected to be ready for implementation in November 2026. This goal reinforces the collaborators' commitment to offering a solution that optimizes the treatment of schizophrenia in both public and private institutions. Besides the clinical impact, Bleuler aims to improve the sustainability of the healthcare system in the long term by reducing costs associated with prolonged treatments. Although the platform is still under development, the projected advancements promise significant benefits for patients and health systems alike.

"Bleuler marks the beginning of a new era in personalized medicine", concluded Trejo de la Rosa. "We are committed to developing innovative solutions that not only transform the treatment of schizophrenia but also set new standards for other complex disorders".
Media Contact
Company Name: 52Platform
Contact Person: Press Office
Email: Send Email [http://www.universalpressrelease.com/?pr=52platform-introduces-bleuler-a-revolutionary-advance-in-schizophrenia-treatment-personalization]
Country: United States
Website: https://www.52platform.com/



This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release 52Platform Introduces Bleuler: A Revolutionary Advance in Schizophrenia Treatment Personalization here

News-ID: 3832682 • Views:

More Releases from Getnews

Best GLP-1 App for 2025: MeAgain Takes Top Position
Best GLP-1 App for 2025: MeAgain Takes Top Position
MeAgain has been recognized as the #1 GLP-1 app in the market, supporting users on medications like Zepbound, Mounjaro, Wegovy, Ozempic, and compounded versions such as Tirzepatide and Semaglutide. The platform offers comprehensive tracking including injection reminders, side effect management, nutrition tracking, and an AI coach for personalized support. Users praise its all-in-one approach: "I used to juggle 4 different apps. This one app now does it all," says user
Springville Freedom Credit Union Expands Auto and RV Loan Services to Better Serve the Community
Springville Freedom Credit Union Expands Auto and RV Loan Services to Better Ser …
Image: https://www.globalnewslines.com/uploads/2025/09/1759164728.jpg Springville Freedom Credit Union has announced expanded offerings designed to make vehicle ownership more accessible and affordable for the community. With a commitment to providing flexible financial solutions, the credit union now offers specialized loan programs to meet the growing demand for reliable transportation and recreational financing. One of the newest offerings includes a New Car Loan Springville [https://www.google.com/maps?cid=7057362679886001310] program, designed to help individuals drive away in the latest models
PushAds.net Launches New AI-Driven Toolkit to Boost Ad Campaign ROI and Targeting Precision
PushAds.net Launches New AI-Driven Toolkit to Boost Ad Campaign ROI and Targetin …
Image: https://www.globalnewslines.com/uploads/2025/09/1758887006.jpg Image by FatAds Platform enhances Smart Bidding, adds Granular Targeting and In-Page Push to address demands for quality and efficiency in push traffic. LIMASSOL, Cyprus - PushAds.net, a rapidly expanding push notification advertising platform, today announced a significant upgrade to its technological infrastructure. The update introduces a new suite of targeting and optimization tools designed to deliver higher Click-Through Rates (CTR) and a superior Return on Investment (ROI) for marketers, affiliates,
Producer/ Director Dale Fabrigar Unleashes Very Frightening Tales Part 2 - Coming Soon
Producer/ Director Dale Fabrigar Unleashes Very Frightening Tales Part 2 - Comin …
Image: https://www.globalnewslines.com/uploads/2025/09/1759088649.jpg Very Frightening Tales 2 | A Horror Anthology Following the success of the chilling anthology Very Frightening Tales, which was picked up by Indian streamer JioStar (aka Disney Star), acclaimed producer/director Dale Fabrigar (D-Railed, They Crawl Beneath) returns with the next terrifying installment: Very Frightening Tales 2. Los Angeles, CA - September 29, 2025 - Following the success of the chilling anthology Very Frightening Tales , which was picked up by

All 5 Releases


More Releases for Bleuler

Revolutionary Breakthrough for Schizophrenia; Bleuler by 52Platform Receives Fun …
Image: https://www.globalnewslines.com/uploads/2025/01/1737537886.jpg Bleuler seeks to redefine clinical management with advanced artificial intelligence and personalized solutions. The project aims to improve patients' quality of life and optimize healthcare system costs. 52Platform [https://www.52platform.com/], a leader in neuroscientific innovation, has announced Bleuler, a revolutionary project aimed at developing a platform to transform the treatment of schizophrenia. Designed with the most advanced capabilities of artificial intelligence, Bleuler aspires to provide personalized solutions based on accurate data. This